Hydrogen Shows Promise for Treating Diabetes and Metabolic Disorders
- Authors
- C.Y. Lv, Y. Zhang, S.M. He, M.X. Yu
- Journal
- Fudan University Journal of Medical Sciences
- Year
- 2014
- DOI
- 10.3969/j.issn.1672-8467.2014.05.024
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Type 2 Diabetes
- Body System
- Endocrine
TL;DR
Scientists found that hydrogen gas might be a safer and better way to fight diseases like diabetes and obesity by reducing harmful inflammation and damage in the body, which could work better than medicines doctors use today.
Key Finding
Animal studies suggest hydrogen has anti-oxidant and anti-inflammatory effects across multiple disease models, particularly metabolic disorders, potentially offering a safer therapeutic option than conventional medications with narrow therapeutic windows.
Summary
This article reviews research on how hydrogen may help treat metabolic diseases like diabetes, obesity, and high cholesterol. Studies in animals have shown that hydrogen can reduce oxidative stress (cellular damage from unstable molecules) and inflammation, two factors involved in these conditions. The authors suggest hydrogen could be a safer alternative to current anti-inflammatory and antioxidant medicines, which often have limited therapeutic windows (narrow ranges where they work safely).
Practical Takeaway
While animal research suggests hydrogen may have promise for metabolic diseases, this is a review article rather than a new study with human results. Significant clinical research in humans would be needed before hydrogen could be recommended as a treatment. Early evidence indicates hydrogen warrants further investigation, but consumers should be cautious about hydrogen products marketed for metabolic health until human trials are completed.
Abstract
Oxidative stress and inflammation play important roles in many diseases, including metabolic diseases, such as diabetes, dyslipidemia, metabolic syndrome, obesity, atherosclerosis and so on. However, the therapeutic windows of a majority of anti-oxidant and anti-inflammatory medicines at present are narrow. So there is a need for a more effective and safer anti-oxidant and anti-inflammatory medicine in clinic. A large number of recent studies show that hydrogen has anti-oxidant and anti-inflammatory effects on a variety of animal models of ischemia-reperfusion injury, inflammation, neurological diseases, digestive diseases and metabolic diseases, suggesting that hydrogen is a potential drug for metabolic diseases. This article reviews the latest development of the researches related and prospects for future research directions.